On Jan. 14, 2022, the U.S. Department of Defense, in coordination with the U.S. Department of Health and Human Services, awarded contracts to Abbott Rapid Dx North America, iHealth Lab, and Roche Diagnostics Corporation (Indianapolis, Indiana), purchasing a combined total of 380 million over-the-counter COVID-19 test kits.

This effort supported the president;s plan to deliver 500 million free at-home COVID-19 tests to the nation in response to the Omicron variant.